SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.58-1.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam Citron who wrote (9742)12/12/2003 9:07:15 PM
From: hmpa  Read Replies (1) of 52153
 
Country that might make a good candidate for large scale clinical trials is India. However, Indian legislation expressly prohibits foreign pharma's drugs to be tested there unless these tests are [not principal] part of a multi-national trial. There is certain amount of clinical testing done in Eastern Europe/former USSR; they have some FDA cleared centers. Some trials run there, however, produced poor quality data (statistics wise - e.g. CBST and EMIS trials, and probably others from the companies I don't follow), so I am not sure there is much growth despite supposedly lower costs and active promotion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News